Stock Locations

New Jersey, USA
Czech Republic, EU
Mumbai, India

* Stock subject to availability.

Documentation

Download MSDS

Download Sample COA

Includes: HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, Structure Elucidation Report (SER), and additional analytical data depending on the product.

854898-53-6Rosuvastatin Calcium Impurity L

● In Stock

Catalogue No.:	VE0026741
CAS No.:	854898-53-6
Mol. Formula:	C22H28FN3O6S
Mol. Weight:	481.54 g/mol

Request a quote

Add to RFQ list

Additional information on CAS 854898-53-6

Parent drug

Rosuvastatin

IUPAC Name

(3R,5S)-5-[(6S)-8-fluoro-2-[methyl(methylsulfonyl)amino]-4-propan-2-yl-5,6-dihydrobenzo[h]quinazolin-6-yl]-3,5-dihydroxypentanoic acid

Smiles

CN(S(C)(=O)=O)C1=NC2=C(C[C@@]([C@@H](O)C[C@@H](O)CC(O)=O)([H])C3=C2C=CC(F)=C3)C(C(C)C)=N1

InChI

InChI=1S/C22H28FN3O6S/c1-11(2)20-17-10-16(18(28)8-13(27)9-19(29)30)15-7-12(23)5-6-14(15)21(17)25-22(24-20)26(3)33(4,31)32/h5-7,11,13,16,18,27-28H,8-10H2,1-4H3,(H,29,30)/t13-,16+,18+/m1/s1

Description

Rosuvastatin Calcium Impurity L (CAS 854898-53-6) is a process-related and degradation-related impurity monitored in rosuvastatin API quality control. Characterization typically employs LC-HRMS and NMR to establish accurate mass, fragmentation pattern, and structural assignment, while quantification is performed by validated HPLC with UV detection against reference standards. Its formation pathways include synthetic route side reactions and oxidative or hydrolytic degradation during storage, making it critical for stability studies. Control strategy focuses on impurity profiling, specification setting in line with ICH Q3A/Q3B thresholds, and optimization of synthetic conditions and purification to minimize levels and ensure batch-to-batch consistency.